Janssen, the pharmaceutical arm of Johnson & Johnson, filed a lawsuit against the U.S. government on Tuesday, joining others trying to prevent a program that allows Medicare the power to negotiate lower drug prices.
The lawsuit, filed in the U.S. District Court for the District of New Jersey, argues that the Medicare drug price negotiation program mandated by President Joe Biden’s Inflation Reduction Act (IRA) will cut profits and hinder the development of groundbreaking treatments.
